Home/Filings/4/0000899243-18-030040
4//SEC Filing

Roberts Margo R 4

Accession 0000899243-18-030040

CIK 0001463361other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:07 PM ET

Size

6.2 KB

Accession

0000899243-18-030040

Insider Transaction Report

Form 4
Period: 2018-12-03
Transactions
  • Award

    Stock Option (right to buy)

    2018-12-03+50,66150,661 total
    Exercise: $13.67Exp: 2028-12-02Common Stock (50,661 underlying)
Footnotes (2)
  • [F1]The number of shares underlying the option grant is based on a grant date value of $450,000, which is calculated using the Black-Scholes pricing model with the volume weighted average trading price of a share of Common Stock on the stock exchange on which the Common Stock is then listed or traded for the thirty (30) consecutive trading days ending on the trading day prior to the date of grant and the volatility, risk-free rate and life expectancy assumptions in the Company's most recent public filings disclosing those assumptions.
  • [F2]The shares subject to the option will vest and become exercisable with respect to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from December 3, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.

Issuer

Unity Biotechnology, Inc.

CIK 0001463361

Entity typeother

Related Parties

1
  • filerCIK 0001609643

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:07 PM ET
Size
6.2 KB